Filing Flows › AstraZeneca (AZN) › CVRM revenue
AstraZeneca (AZN) CVRM revenue by quarter
AstraZeneca's CVRM revenue was $2.6B in Q3 2026 (third quarter 2026), -20% from Q1 2026. Over the last 3 quarters it ranged from $2.6B (Q3 2026) to $3.3B (Q1 2025).
| Quarter | CVRM revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.6B | -20% | — |
| Q1 2026 | $3.2B | -2% | -2% |
| Q1 2025 | $3.3B | — | — |
Q3 2026 at a glance
AstraZeneca, Q3 2026: revenue $16.2B (+7% year over year), operating margin 27.1%, net earnings $3.1B, operating cash flow $5.8B. The chart follows the revenue to costs, profit and cash.
Questions
What is AstraZeneca's CVRM revenue?
AstraZeneca's CVRM revenue was $2.6B in Q3 2026 (third quarter 2026), -20% from Q1 2026.
How has AstraZeneca's CVRM revenue changed?
Over the last 3 quarters it ranged from $2.6B (Q3 2026) to $3.3B (Q1 2025).